Taken from Ihub snoop
December 10, 2020 Notice Declaring Intention to be Qualified under National Instrument 44-101 (NI 44-101) Short Form Prospectus Distributions To: Ontario Securities Commission And To: British Columbia Securities Commission Alberta Securities Commission Revive Therapeutics Ltd. (the Issuer) intends to be qualified to file a short form prospectus under NI 44- 101. The Issuer acknowledges that it must satisfy all applicable qualification criteria prior to filing a preliminary short form prospectus. This notice does not evidence the Issuers intent to file a short form prospectus, to enter into any particular financing or transaction or to become a reporting issuer in any jurisdiction. This notice will remain in effect until withdrawn by the Issuer. Revive Therapeutics Ltd. Michael Frank Michael Frank Chief Executive Officer Copy and paste from sedar